Must-see Affielisa® Human Cell Division Cycle Protein 23 Homolog Elisa [ Cdc23] (new) [HuvdXeqz]

AffiELISA® Human Cell Division Cycle Protein 23 Homolog ELISA [CDC23]

Introducing the AffiELISA® Human Cell Division Cycle Protein 23 Homolog ELISA [CDC23], a cutting-edge diagnostic tool designed for accurate and efficient detection of cell division cycle protein 23 homolog (CDC23) in various biological samples. This high-quality ELISA kit offers a reliable and sensitive method for researchers and clinical professionals to study the role of CDC23 in cell cycle regulation and its potential applications in cancer research, developmental biology, and other areas of study. With its user-friendly design and consistent performance, the AffiELISA® kit is an essential tool for any laboratory involved in cell cycle research.

Product Properties and Specifications

The AffiELISA® Human Cell Division Cycle Protein 23 Homolog ELISA [CDC23] is carefully formulated to ensure accurate and reproducible results. This kit features a unique antibody pair that specifically recognizes and binds to CDC23, minimizing cross-reactivity with other proteins. The kit includes all necessary reagents, including standards, controls, and buffers, to streamline the experimental process. With a detection limit as low as 15 pg/mL, this ELISA kit provides sensitive and reliable measurements of CDC23 levels in your samples. The kit is also designed for high-throughput analysis, making it suitable for large-scale studies and research projects.

Practical Uses and Target Audience

The AffiELISA® Human Cell Division Cycle Protein 23 Homolog ELISA [CDC23] is an invaluable tool for researchers in a wide range of fields. Its applications include the study of cell cycle regulation, identification of potential cancer biomarkers, and investigation of developmental processes. Ideal for use in clinical laboratories, academic research institutions, and pharmaceutical companies, this ELISA kit is perfect for professionals who require precise and reliable detection of CDC23 in their studies. With its ease of use and consistent performance, the AffiELISA® kit is the go-to choice for researchers and clinicians alike, ensuring accurate results and advancing the frontiers of cell cycle research.